# Innate Pharma SA: Form 6-K, filed Feb 6, 2024

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2024-02-06
- Accepted by EDGAR: Feb 6, 2024, 17:05 ET
- Period: 2024-02-06
- Accession: 0001628280-24-003515
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000162828024003515/innatepharma6-k262024.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000162828024003515/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000162828024003515/innatepharma6-k262024.htm

Filed Feb 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001628280-24-003515. Last ingested by Listed: Nov 12, 2026, 17:11 ET. No prices; not investment advice.